| Views | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 299 |
| July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 3 | 6 | 5 | 2 | 5 | 1 | 1 |
| Views | |
|---|---|
| 1065.full.pdf | 166 |
